Thanks, everyone. good morning, Joe, and
for reiterate begin, I would presentation I financial remarks our to like results of the the regarding Joe's quarter. third Before
prior adjusted operations. have to on reflect our the schedules Beginning this available quarter, Care historical period operations business been The discontinued the now is results and are restated company's reported presentation, website. discontinued as Kidney
[indiscernible] commentary surrounding both For issued provided quarter on be company comparability total our performance a guidance, third continuing purposes, basis. previously and operations will
quarter. Now comments the specific regarding turning to some
to with and previously the As guidance in came Joe the favorably line our bottom pleased which issued third quarter on our we're with line line. compared expectations top our on general, in mentioned, results,
in Excluding on quarter $X.XX Drug in a both on all and constant therapies, U.S. softness from patient and with which Compounding Injectables Sales and prior a increased more both therapies, currency X% the effect of segments than Performance growth. offset HST. billion year infusion basis. better-than-expected & currency constant in basis and X% company has quarter Anesthesia in sales continuing contributing total reflected to sales reported support chronic systems, XXXX operations of reported third sales period, the increased BPS global the
On lower raised the including total $X.XX company to quarter excludes $X.XX our Kidney performance which per driven interest increased compared discontinued and from prior earnings prior growth operations, Care, and and of was and the totaled Earnings both prior to sales Adjusted bottom per operations, of per by to line, in year. share share. ahead earnings, periods expense adjusted $X.XX continuing the operational operations guidance year the XX% for continuing as compared period. share EPS
or sales ahead walk coming were at I'll & increasing reported by billion, and $X.X in results in Therapies Products our segment constant our of segments. Sales currency Medical expectations. growth Now rates. reflects regarding Commentary X% growth through MPT
coming $X.X therapies infusion both continues benefited billion the third new to systems IQ pump the MPT, platform our growth Within U.S. customers. Novum from our and and build for infusion totaled our increased in significant in momentum technologies quarter rollout X%. as portfolio sales of from division from orders Sales existing and with quarter
sales pricing U.S. favorable customer driven also internationally continued pump. and volume performance benefited to IV in infusion spectrum The deliver for systems demand. underlying the strong from quarter solid our solutions demand by
in also portfolio quarter $XXX hemostats our well to ICT of as Surgery nutrition the Advanced Results growth the for prices. as Sales Mid-single-digit reflect performance million globally. sealants favorable and quarter. globally demand totaled in contributed and in in X% grew
margin represented of basis in resulted performance an in basis operational sequentially. which and quarter, sales improvement of adjusted points XX% Strong year-over-year and for operating the MPT XXX points XX
quarter the For Healthcare and in increased X%. $XXX Systems or sales million our & Technologies segment, HST were
CCS growing the $XXX sales Within were segment, or & our HST Solutions Connectivity million, Care X%. of division
capital Patient quarter U.S. the by PSS Orders strength in Support which the was growth. existing in PSS Performance by driven or business, double-digit U.S. our Systems driven delivered in mid-teens continued release for initiatives increased sales government of accounts stimulus in and policy Performance in partially offset [indiscernible]. and driven a to ongoing competitive by U.S. was China by due outside delay weaker funding. the the softness quarter the
demand Western funding. market exits year-over-year weaker In due due delayed addition, declined certain a to and Europe sales in to on government basis
growth the we installations are for strong have order business, installs care, of communications periods. performance seen and year-to-date, sales timing hospital by been customers While of to many future our our impacted delaying has connectivity as
is strong, this see these we for we rate into low cancellation as XXXX. backlog very installs Our such, and have business. a phasing many And of
Finally, business the as period compared prior to to Global declined sales resolved the company constraints, Solutions ongoing be our year end or which of continues quickly largely for due and to work remediate to year. expects the GSS Surgical by the supply to
to to in sales growth Care million $XXX Line the quarter in the Growth prior a year year backlog the were in period. impacted difficult and prior as Front X%. contributed in reductions comparison continue quarter declined the positively be by
by to impacted softness also was ongoing care quarter the primary in market. the Performance
in challenging dynamics in care market. our have been primary have contact distributor acknowledged close market with partners, who We U.S. the also
market Our is current the that of stabilize begins the assumption course XXXX. over to
and HST basis margins during quarter XX.X% points in XXX significant efficiency. HST adjusted expansion Notably, year-over-year points basis XXX increased recognized the margins driven sequentially. improved of operating operating third quarter by operational
Performance segment which Moving a mid-single-digit the of within Sales million, comparison benefited digits. in in being driven X%. were increasing by in Sales difficult out injectables Injectables from & our high prior market. declined a Pharmaceuticals. on portfolio competitor period, to reflected Anesthesia year decline the a this to the quarter $XXX single
by in the new quarter the of performance shifting product impacted some the United Supply quarter addition, anticipated to fourth launch. delay In sales in the outside impacted and also States constraints the in were quarter. orders
anesthesia the [indiscernible] and in sales mid-teens to quarter. continue declined Lower our performance in
business quarter. As to Joe mentioned, we the have start seen fourth this sales in rebound
to injectable to new continues months enhance of the targeting products product coming the and addition, launch team In is the launch over the its new volume given years. team playbook,
strong services continued Compounding, demand resulting growth. double-digit in quarter, for Within Drug in the
and quarter, Given lower margins Pharmaceuticals sales year-over-year sequentially. both in Injectables declined & Anesthesia in the
injectables integrated Pharmaceuticals the adjusted executing keenly for through on improvement supply the in Pharmaceuticals with expanding The on accelerating, margin business action X.X% taking anesthesia initiatives growth driving team improvements margins chain. is operating quarter. margins were and compounding the business, mix focused stabilizing cost and improved
the segment Strong Sales in from increasing in Care, increasing quarter therapies the partially P&E growth billion, and quarter $X.X Care our business. for in-center the our expected was product Kidney X%. chronic HD were exits Kidney sales offset global X%. totaled for certain Within million, impact $XXX in market by negative
quarter. driven in million Other a sales Sales products States. million, our through were during demand of $XX certain sales by business United Acute and to $XXX the not facilities our and provided and strong Therapies includes the which of directly were represent representing growth primarily manufacturing increased of allocated sales, X% XX% in services segment
the Before our P&L moving on regarding rest some to of to results, wanted the I operations make results. comments continuing
Care Care in sale Kidney change the now the operations, pending been Kidney convey are costs. Kidney the and unallocated Care the previously segment business discontinued had move in results that allocated to not costs and reported with corporate business corporate reporting Given to will
results stranded undertaking. to prior the mostly and as TSAs costs These is in in of impact may the from expected be in be periods through Vantive on transition XXXX received offset Vantive's initiatives well cost-containment process but the to company service income agreements as or quarter are
by the offset impact of expect costs stated, [indiscernible] fully we end and to XXXX. currently As the previously stranded loss of we income of these
prior as within points network primarily pricing Kidney and select year-over-year expansion initiatives expansion our gross the was continued basis total supply in integrated chain an mix partially over quarter the of offset markets. gross represented The adjusted in Overall, margin including XX.X% Third as reflects efficiencies product operations margin quarter. discontinued company margin, increase in from well year. the XX Care,
sale year XX.X% Adjusted following XXX contract gross mix of basis the the into prior of margin period totaled in from points and a quarter entered the driven declined agreement BPS. manufacturing continuing operations and we versus by the impact the
as we operations operations including line prior SG&A, increase $XXX entered or or make the is sales. XX Adjusted as into versus the to BPS basis select prior points million percentage a continue XX support totaled launches. product P&L XX.X% increase expense, SG&A year. which million of basis from discontinued other an in [indiscernible] as from item period totaled percentage the sales, Care, points operating company referred of XX.X% our a This as and of TSAs received objectives partially increase another investments from of income reflects $XXX an offset and Adjusted to new growth following continued has the income year sales, from Kidney to of
operations the of investments across for portfolio a of patients prior X.X% the in $XXX bringing including spending sales, our Care, across reflects continued and to our million in quarter, products percentage R&D compared Kidney XX represented the increase discontinued new innovation points as adjusted advancing an year and Total totaled segments. period basis and to
operations R&D factors a and basis from X.X% an of prior totaled Adjusted margin as increase well $XXX factors basis from as discontinued inclusive of foreign versus in prior a of percentage XX year. above an year the by of favorable These driven XX versus resulted million decreased as continued points points operations, impact XX.X%, adjusted exchange. operating or the sales
operating by for basis approximately stranded approximate reflect operating which on year-to-date of from quarter. $XX headwind continuing XXX of a XXX in as continuing the operating reflection stranded operations margins million XX.X% adjusted million costs. points Adjusted margin margin impact basis negatively negative $XXX costs, operations XXXX totaled points or impacted
year divestiture. million totaled the repayments the expense BPS Net quarter, proceeds with completed prior from driven debt $XX decrease $XX of versus by a interest our million in period the
in $X operations $XX million of in income nonoperating prior million income income in quarter million compared from year to the period. the $X prior totaled the million totaled of compared Adjusted the other in year. continuing quarter other nonoperating Adjusted $X income to
The to R&D points adjusted in discontinued changes Care, expectations. earnings compared prior base tax prior rate total and Kidney incremental in the [indiscernible], including basis The year. is was for the tax primarily year lower by the credit XXX from versus driven and came company quarter, than the slightly operations as year-over-year decreasing decrease in benefits U.S.
And commercial per the interest totaled share Year-to-date versus earnings increased the driven reflecting continuing total to $X.XX $X.XX versus adjusted quarter in prior from increasing per reduction operations share, and improved period share the to prior primarily and stranded XX% were earnings $X.XX costs. year mentioned, by prior related a and continuing XX% $X.XX totaled Adjusted period from the for earnings per performance per related expense. share, reflected and per adjusted as XX% operations headwind $X.XX share an increasing an previously versus headwind stranded costs. approximate
Let me guidance. underpinning full for including assumptions fourth by XXXX, some key our outlook the conclude discussing year remarks my the quarter and
adjusted the outlook our impact given the we production, estimated and First, year of reflect Cove Hurricane of the impact fourth XXXX full unprecedented operations North quarter the have on on hurricane results. Helene company's related financial to our
to We to on million million total impact expect sales. quarter fourth sales including company Kidney approximately $XXX $XXX negatively million the $XXX impact and from by $XX estimated $XX on the approximately million million, impact an to hurricane effects sales Care MPT
discontinued impacted expected adjusted per earnings operations, share, to by per $X.XX to be company share. Total $X.XX negatively including are
total discontinued provided operations. In BPS excludes impact of company basis the includes impact of Kidney Care on the discontinued a operations all addition, and guidance
of of on approximately Hurricane operations currency expects Baxter X% top basis basis, basis, approximately full year X% from negative growth from continuing a XXXX, Baxter inclusive points X% sales basis constant of X% Based on a factors, and both currency XXX-plus Hurricane total Helene. and now On sales basis, negative constant reflecting reported point a impact as Helene. an reported XXX for growth approximately line impact these expects on to
year currency segments by is guidance Constant the sales for reportable as follows. full
we now basis digits, the now U.S. increase HST single MPT, of in expect a negative For Hurricane reflecting decline are primary year-to-date low expected and Shares recovery X%, to results Helene. reflecting slow continued care. market segment point impact sales X% to XXX-plus to from our
& [indiscernible] We to of sales sales phasing XX%, in in expect the Drug Anesthesia quarter Pharmaceuticals increase fourth reflects approximately and some Compounding. better continue Injectables to which the
Care, an this inclusive and prior For of compares Helene. point guidance This reflects favorably basis underlying now sales the XXX momentum expect we X%, business. approximately of from Kidney to growth of approximate headwind Hurricane
P&L Now items. turning our line to other for outlook
We basis expect XXXX, points to in than margin adjusted headwind continue operating approximate inclusive Helene. margin from by to to XX basis of operating Hurricane full year adjusted increase full an point more year XX
decline On headwind XX expected operating basis a XXXX expects points. margin operations Baxter points. adjusted continuing by year from approximately XXX is basis, to adjusted basis XXX margins impact to operating to full costs stranded The
of Full costs. margins stranded negative year XXXX from operating XX.X% reflected point adjusted XXX approximately basis impact
expense, approximately include aggregate approximately on operations net XXXX $XXX expect nonoperating other income to million and expense interest which in $XXX We and basis. our expenses, total a or continuing million during
we a On total full year approximately XX.X%. full approximately tax now continuing anticipate year adjusted a of a rate We XX%. anticipate basis, of company operations rate tax
expect We XXX year. for million shares average count share diluted the our to
items Based adjusted $X.XX excluding diluted and of operations, discontinued to $X.XX $X.XX we on $X.XX special per Helene. year Hurricane of all reflects to This earnings, share. guidance headwind anticipate per these from the factors, share inclusive total full now company
the the discontinued the be operation approximately reporting on adjusted company reflected of quarter, makes Care operations. of accounting Kidney to GAAP requires Care year This per $X.XX Kidney benefit will share, a guidance as and to change Additionally, assets. classified a amortization that discontinued U.S. full cease certain in met the in be the business which criteria depreciation given
adjusted operations $X.XX and continuing $X.XX per approximately before $X.XX headwind and reflect per from Hurricane Helene year per costs. earnings $X.XX an of the a XXXX earnings share, expect per costs. we items full approximate $X.XX share reflecting year per continuing headwind impact of negative adjusted operations share special from On share stranded basis, stranded share full to from
Helene. guidance XXXX, is expect negative both continuing of basis of single sales Hurricane on digits XXX and headwind fourth basis. This total decline to the low a to we inclusive point from operation company Specific reported currency and quarter constant
of total $X.XX per diluted and per of expect the approximately reflects to and an a special items hurricane to $X.XX earnings, benefit. headwind $X.XX [indiscernible], inclusive outlook share. company depreciation This of share adjusted share to per We related $X.XX excluding $X.XX
On a impact negative an stranded we basis, adjusted $X.XX of share, items to headwind operations earnings from continuing share for Helene $X.XX Hurricane costs. per per reflecting before $X.XX the per approximately and expect special share
we the now call up open Q&A. that, can for With
